Cargando…

The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis

BACKGROUND: Gastric cancer is a global health problem with high incidence rate and mortality rate. Due to the limitations of traditional chemotherapy drugs, such as patient intolerance, low efficacies and serious adverse effects, trifluridine/tipiracil has been considered to be a promising treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaoyan, Zhang, Tianyao, Wu, Lijuan, Wu, Yongcan, Zhou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808477/
https://www.ncbi.nlm.nih.gov/pubmed/33466182
http://dx.doi.org/10.1097/MD.0000000000024110
_version_ 1783636906208133120
author He, Xiaoyan
Zhang, Tianyao
Wu, Lijuan
Wu, Yongcan
Zhou, Xin
author_facet He, Xiaoyan
Zhang, Tianyao
Wu, Lijuan
Wu, Yongcan
Zhou, Xin
author_sort He, Xiaoyan
collection PubMed
description BACKGROUND: Gastric cancer is a global health problem with high incidence rate and mortality rate. Due to the limitations of traditional chemotherapy drugs, such as patient intolerance, low efficacies and serious adverse effects, trifluridine/tipiracil has been considered to be a promising treatment for patients with heavily pretreated metastatic gastric cancer. However, the relevant systematic review has not been occurring. The presentation of this protocol is to scientifically evaluate the efficacy and safety of trifluridine/tipiracil in patients with highly pretreated metastatic gastric cancer. METHODS: The protocol followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. We will systematically search MEDLINE, PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure Database (CNKI), VIP Chinese Science and Technology Periodical Database (VIP), Wan Fang Database up to November 1, 2020 to identify published articles. Using the Cochrane risk assessment tool to assess the methodological quality of the RCTs, and all included studies will be analyzed according to the criteria in the Cochrane Handbook. Review Manager 5.3 software will be used for literature quality evaluation and data analysis. RESULTS: Objective to evaluate the efficacy and safety of trifluridine/tipiracil in patients with heavily pretreated metastatic gastric cancer by analyzing the eligible data extracted under limited conditions. CONCLUSION: This study provides clear evidence to evaluate the effectiveness and safety of trifluridine/tipiracil for patients with highly pretreated metastatic gastric cancer, and the findings will also be published in a peer-reviewed journal. ETHICS AND DISSEMINATION: No ethical statement will be required for this study because there is no direct involvement of human. This review will be published in a peer-reviewed journal as a conference report or an article. REGISTRATION: OSF registration number: DOI 10.17605/OSF.IO/6MF5U.
format Online
Article
Text
id pubmed-7808477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78084772021-01-15 The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis He, Xiaoyan Zhang, Tianyao Wu, Lijuan Wu, Yongcan Zhou, Xin Medicine (Baltimore) 4500 BACKGROUND: Gastric cancer is a global health problem with high incidence rate and mortality rate. Due to the limitations of traditional chemotherapy drugs, such as patient intolerance, low efficacies and serious adverse effects, trifluridine/tipiracil has been considered to be a promising treatment for patients with heavily pretreated metastatic gastric cancer. However, the relevant systematic review has not been occurring. The presentation of this protocol is to scientifically evaluate the efficacy and safety of trifluridine/tipiracil in patients with highly pretreated metastatic gastric cancer. METHODS: The protocol followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. We will systematically search MEDLINE, PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure Database (CNKI), VIP Chinese Science and Technology Periodical Database (VIP), Wan Fang Database up to November 1, 2020 to identify published articles. Using the Cochrane risk assessment tool to assess the methodological quality of the RCTs, and all included studies will be analyzed according to the criteria in the Cochrane Handbook. Review Manager 5.3 software will be used for literature quality evaluation and data analysis. RESULTS: Objective to evaluate the efficacy and safety of trifluridine/tipiracil in patients with heavily pretreated metastatic gastric cancer by analyzing the eligible data extracted under limited conditions. CONCLUSION: This study provides clear evidence to evaluate the effectiveness and safety of trifluridine/tipiracil for patients with highly pretreated metastatic gastric cancer, and the findings will also be published in a peer-reviewed journal. ETHICS AND DISSEMINATION: No ethical statement will be required for this study because there is no direct involvement of human. This review will be published in a peer-reviewed journal as a conference report or an article. REGISTRATION: OSF registration number: DOI 10.17605/OSF.IO/6MF5U. Lippincott Williams & Wilkins 2021-01-15 /pmc/articles/PMC7808477/ /pubmed/33466182 http://dx.doi.org/10.1097/MD.0000000000024110 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 4500
He, Xiaoyan
Zhang, Tianyao
Wu, Lijuan
Wu, Yongcan
Zhou, Xin
The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title_full The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title_fullStr The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title_full_unstemmed The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title_short The effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: A protocol for systematic review and meta-analysis
title_sort effect of trifluridine/tipiracil for patients with heavily pretreated metastatic gastric cancer: a protocol for systematic review and meta-analysis
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808477/
https://www.ncbi.nlm.nih.gov/pubmed/33466182
http://dx.doi.org/10.1097/MD.0000000000024110
work_keys_str_mv AT hexiaoyan theeffectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT zhangtianyao theeffectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT wulijuan theeffectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT wuyongcan theeffectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT zhouxin theeffectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT hexiaoyan effectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT zhangtianyao effectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT wulijuan effectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT wuyongcan effectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis
AT zhouxin effectoftrifluridinetipiracilforpatientswithheavilypretreatedmetastaticgastriccanceraprotocolforsystematicreviewandmetaanalysis